Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia

Background The main advantage of GeneXpert MTB/RIF ® (Xpert) molecular diagnostic technology is the rapid detection of M .tuberculosis DNA and mutations associated with rifampicin (RIF) resistance for timely initiation of appropriate treatment and, consequently, preventing further transmission of th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC infectious diseases Jg. 20; H. 1; S. 1 - 9
Hauptverfasser:	Ershova, Julia V., Volchenkov, Grigory V., Somova, Tatiana R., Kuznetsova, Tatiana A., Kaunetis, Natalia V., Kaminski, Dorothy, Demikhova, Olga V., Chernousova, Larisa N., Vasilyeva, Irina A., Kerr, Eleanor M., Cegielski, J. Peter, Kurbatova, Ekaterina V.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 25.07.2020 BioMed Central Ltd Springer Nature B.V BMC
Schlagworte:	Clinical outcomes Diagnosis Diagnostic systems Disease transmission Drug resistance GeneXpert MTB/RIF Health services HIV Human immunodeficiency virus Imprisonment Infectious Diseases Internal Medicine Medical Microbiology Medical research Medicine Medicine & Public Health Mutation Parasitology Patient outcomes Patients Rank tests Research Article Rifampicin Rifampin Statistical analysis Survival analysis Tropical Medicine Tuberculosis Tuberculosis and other mycobacterial diseases Russia Drug resistance Rifampicin GeneXpert MTB/RIF
ISSN:	1471-2334, 1471-2334
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!